Characteristics, Treatment Strategies, and Long-term Health Outcomes of People With Bedaquiline-resistant Tuberculosis in Karakalpakstan, Uzbekistan-A Retrospective Cohort Study. [PDF]
Saunders MJ +16 more
europepmc +1 more source
Cerebrospinal Fluid Concentrations of Bedaquiline, Pretomanid, and Linezolid During Curative Treatment of Fluoroquinolone-Resistant Pre-Extensively Drug-Resistant Tuberculous Meningitis. [PDF]
Tramontana AR +8 more
europepmc +1 more source
Real-world treatment outcomes and adverse events during BPaLM therapy for rifampicin-resistant TB. [PDF]
Choong CV +6 more
europepmc +1 more source
A simple, accurate, precise, and economical RP-HPLC method was developed and validated for the simultaneous estimation of Delamanid and Bedaquiline in bulk drug and pharmaceutical dosage forms. Chromatographic separation was achieved using a Kromasil C18
Nagaraju P, Srinivas N
core +1 more source
We Are Underprepared for Bedaquiline Resistance: A Call for Clinical and Programmatic Readiness. [PDF]
Cross GB, Walker HN, Hasan T, Berry C.
europepmc +1 more source
Central nervous system antituberculosis drug exposures in a rabbit model of tuberculous meningitis. [PDF]
Calderin JM +12 more
europepmc +1 more source
Analytical Method Development and Validation for Clofazimine in Human Plasma and Application of LC-MS/MS Based Methods for Clofazimine and Bedaquiline in Indian MDR-TB Patients Stratified by HIV Coinfection. [PDF]
Lokhande RV +17 more
europepmc +1 more source
Treatment of multidrug-resistant tuberculosis with bedaquiline, pretomanid, linezolid, and moxifloxacin following near-total gastrectomy. [PDF]
Weheba I +3 more
europepmc +1 more source
Emergence of dual bedaquiline and linezolid resistance during treatment of pre-extensively drug-resistant tuberculosis: A case report from Zambia. [PDF]
Kalaba D +5 more
europepmc +1 more source
Rapid detection of treatment-emergent resistance to bedaquiline and pretomanid in <i>Mycobacterium tuberculosis</i> using TM4::<i>GeNL</i> reporter mycobacteriophages. [PDF]
Ngema SL +9 more
europepmc +1 more source

